Non-small cell lung cancer
Conditions
Interventions
Early-stage NSCLC:None
Advanced-Stage Non-Small Cell Lung Cancer:None
Sponsors
Nationa Cancer Center, National
Clinical Research Center for Cancer,
Cancer Hospital, Chinese Academy
of Medical Sciences and Peking
Union Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Age of the patient: =18 and =75 years; 2. No prior anticancer treatment before surgery; 3.No history of other tumors, past or concurrent; 4.Underwent radical surgery for lung cancer between November 2020 and October 2022; 5. Postoperative pathological diagnosis of non-small cell lung cancer, with staging between Ia and IIIb; 6. Able to comply with study requirements and has signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with non-small cell lung cancer who have received tumor-related treatments before surgery (including chemotherapy, radiotherapy, targeted therapy, and immunotherapy); 2. Patients with severe cardiac, pulmonary, hepatic, cerebral, or renal dysfunction who are unable to tolerate surgery; 3. Pregnant patients; 4.Patients with concurrent other malignancies; 5.Patients with severe underlying diseases that make them unable to tolerate surgery; 6.Patients with types of lung cancer other than non-small cell lung cancer or with secondary malignant tumors in the lung.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Circulating Tumor Cells (CTCs); | — |
Countries
China
Contacts
Public ContactYousheng Mao
Nationa Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Outcome results
None listed